Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Colby S Shemesh

5PUBLICATIONS

32CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jul 06, 2024

PARP inhibition with rucaparib alone followed by combination with atezolizumab: Phase Ib COUPLET clinical study in advanced gynaecological and triple-negative breast cancers.

Rebecca Kristeleit, Alexandra Leary, Ana Oaknin

|Aug 31, 2023

Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma).

Alexandra Drakaki, Thomas Powles, Aristotelis Bamias

|May 22, 2023

Early Decision Making in a Randomized Phase II Trial of Atezolizumab in Biliary Tract Cancer Using a Tumor Growth Inhibition-Survival Modeling Framework.

Colby S Shemesh, Phyllis Chan, Mathilde Marchand

|Oct 02, 2021

Pharmacology-based ranking of anti-cancer drugs to guide clinical development of cancer immunotherapy combinations.

Vincent Lemaire, Colby S Shemesh, Anand Rotte

|Nov 26, 2020

Pan-cancer population pharmacokinetics and exposure-safety and -efficacy analyses of atezolizumab in patients with high tumor mutational burden.

Colby S Shemesh, Phyllis Chan, Fatema A Legrand

Pageof 1

Frequent Collaborators

1 joint publications

Vincent Lemaire

1 joint publications

Phyllis Chan

1 joint publications

Antonio Gonçalves

1 joint publications

Benjamin Wu

1 joint publications

Stephen P Hack

1 joint publications

Rene Bruno

1 joint publications

Alexandra Drakaki

1 joint publications

Thomas Powles

1 joint publications

Aristotelis Bamias

1 joint publications

Juan Martin-Liberal

Frequent Collaborators

1 joint publications

Vincent Lemaire

1 joint publications

Phyllis Chan

1 joint publications

Antonio Gonçalves

1 joint publications

Benjamin Wu

Top Related Videos

Silencing of <em>BRCA2</em> to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Silencing of <em>BRCA2</em> to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on : Aug 12, 2015

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on : Feb 12, 2017

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

See more related videos

Top Related Videos

Silencing of <em>BRCA2</em> to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Silencing of <em>BRCA2</em> to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on : Aug 12, 2015

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on : Feb 12, 2017

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

See more related videos